undamentalytics Newsletter
Sign in

Orthopediatrics Corp income statement

In fiscal 2025, Orthopediatrics Corp reported revenue of $236m, up 15.4% on the year before, operating income of −$39.2m (a -16.6% margin) and net income of −$39.6m, or −$1.69 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue31374658737198122149205236264
Cost of revenue91111151816253237566469
Gross profit2226344355557391111149173195
Research and development22356568111199
Selling and marketing151721273132404653647381
General and administrative111217212738465873103120126
Operating income−7−6−6−10−9−27−18−25−27−35−39−25
Interest expense11224302−0369
Net interest income————−4−3−2−20———
Income before tax——−9−12−13−34−17−4−21−42−39−34
Income tax00000−1−1−5−0−400
Net income−8−7−9−12−14−33−161−21−38−40−34
Diluted EPS−$2.42−$2.38−$1.95−$0.96−$0.94−$1.82−$0.84$0.06−$0.92−$1.64−$1.69−$1.42
Diluted shares (average)5m5m12m13m15m18m19m21m23m23m23m24m
EBITDA−5−4−4−7−4−19−7−12−9−16−18−2

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: KIDS vs LMATAXGN vs KIDSCERS vs KIDSESTA vs KIDS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Orthopediatrics Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Orthopediatrics Corp.